References
- Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol. 2006; 12:17–20.
- Fock KM, Ang TL. Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. J Gastroenterol Hepatol. 2010; 25:479–86.
- International Agency for Research on Cancer. GLOBOCAN [Internet]. 2012 [cited 2017 Jul 05]. Available from: http://globocan.iarc.fr/
- Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, et al. Recent patterns in gastric cancer: a global overview. Int J Cancer. 2009; 125:666–73.
- Hussein NR. Helicobacter pylori and gastric cancer in the Middle East: A new enigma? World J Gastroenterol. 2010; 16:3226–34.
- Malekzadeh R, Derakhshan MH, Malekzadeh Z. Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med. 2009; 12:576–83.
- Haidari M, Nikbakht MR, Pasdar Y, Najaf F. Trend analysis of gastric cancer incidence in Iran and its six geographical areas during 2000-2005. Asian Pac J Cancer Prev. 2012; 13:3335–41.
- Matsuhisa T, Aftab H. Observation of gastric mucosa in Bangladesh, the country with the lowest incidence of gastric cancer, and Japan, the country with the highest incidence. Helicobacter. 2012; 17:396–401.
- Howlader N, Ries LA, Stinchcomb DG, Edwards BK. The impact of underreported Veterans Affairs data on national cancer statistics: analysis using population-based SEER registries. J Natl Cancer Inst. 2009; 101:533–6.
- Zeraati H, Amiri Z. Estimating postoperative survival of gastric cancer patients and factors affecting it in Iran: based on a TNM-7 Staging System. Acta Med Iran. 2016; 54:114–8.
- Adham D, Abbasgholizadeh N, Abazari M. Prognostic factors for survival in patients with gastric cancer using a random survival forest. Asian Pac J Cancer Prev. 2017; 18:129–34.
- Dikshit RP, Mathur G, Mhatre S, Yeole BB. Epidemiological review of gastric cancer in India. Indian J Med Paediatr Oncol. 2011; 32:3–11.
- Dickman PW, Coviello E. Estimating and modeling relative survival. Stata J. 2015; 15:186–215.
- Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med. 2006; 260:103–17.
- Lambert PC, Dickman PW, Osterlund P, Andersson T, Sankila R, Glimelius B. Temporal trends in the proportion cured for cancer of the colon and rectum: a population-based study using data from the Finnish Cancer Registry. Int J Cancer. 2007; 121:2052–9.
- Lambert PC, Thompson JR, Weston CL, Dickman PW. Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics. 2007; 8:576–94.
- Eloranta S, Lambert PC, Andersson TM, Bjorkholm M, Dickman PW. The application of cure models in the presence of competing risks: a tool for improved risk communication in population-based cancer patient survival. Epidemiology. 2014; 25:742–8.
- Andersson TM, Dickman PW, Eloranta S, Lambert PC. Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models. BMC Med Res Methodol. 2011; 11:96. doi: 10.1186/1471-2288-11-96
- Cronin KA, Feuer EJ. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival. Stat Med. 2000; 19:1729–40.
- Lambert PC, Dickman PW, Nelson CP, Royston P. Estimating the crude probability of death due to cancer and other causes using relative survival models. Stat Med. 2010; 29:885–95.